A Young Biotech Firm’s Dilemma
Should publicly held, early stage biotechs issue more shares or partner with Big Pharma?
Brand Value Drives Corporate Value
With the right brand-value metrics and framework, managements can allocate marketing resources to improve both short- and long-term value creation.
How to Tell Good Buybacks from Bad Ones
Buyback ROI, a tool first introduced on CFO.com, can be used by executives and investors to determine when buybacks are more likely to be successful.
Why Great Health Care Companies Aren’t Necessarily Great Stocks
Performance metrics related to improvement or growth demonstrate the most positive relationships to shareholder return.
In Health Care, Reinvestment Outshines Dividends, Buybacks, Debt
To drive shareholder returns in health care, CFOs should stress financial policies that build financial flexibility rather than leverage.
Is Accounting Blocking R&D Investments?
Companies should resist the urge to cut research expenses to meet an earnings per share target.